COVID-19: Implications for People with Chagas Disease.


Journal

Global heart
ISSN: 2211-8179
Titre abrégé: Glob Heart
Pays: England
ID NLM: 101584391

Informations de publication

Date de publication:
13 Oct 2020
Historique:
entrez: 5 11 2020
pubmed: 6 11 2020
medline: 5 2 2021
Statut: epublish

Résumé

As the global COVID-19 pandemic advances, it increasingly impacts those vulnerable populations who already bear a heavy burden of neglected tropical disease. Chagas disease (CD), a neglected parasitic infection, is of particular concern because of its potential to cause cardiac, gastrointestinal, and other complications which could increase susceptibility to COVID-19. The over one million people worldwide with chronic Chagas cardiomyopathy require special consideration because of COVID-19's potential impact on the heart, yet the pandemic also affects treatment provision to people with acute or chronic indeterminate CD. In this document, a follow-up to the WHF-IASC Roadmap on CD, we assess the implications of coinfection with SARS-CoV-2 and

Identifiants

pubmed: 33150134
doi: 10.5334/gh.891
pmc: PMC7566506
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

69

Subventions

Organisme : NICHD NIH HHS
ID : R01 HD095857
Pays : United States

Informations de copyright

Copyright: © 2020 The Author(s).

Déclaration de conflit d'intérêts

The authors have no competing interests to declare.

Références

Lancet Gastroenterol Hepatol. 2020 Jun;5(6):525
pubmed: 32220656
PLoS Negl Trop Dis. 2016 Jan 04;10(1):e0004269
pubmed: 26727000
Geroscience. 2020 Aug;42(4):1021-1049
pubmed: 32430627
Parasite Immunol. 2014 Aug;36(8):377-87
pubmed: 24611805
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
PLoS Negl Trop Dis. 2016 Nov 7;10(11):e0005033
pubmed: 27820837
J Clin Virol. 2020 Jul;128:104395
pubmed: 32417675
Ann Trop Med Parasitol. 2007 Jan;101(1):31-50
pubmed: 17244408
Cardiovasc Res. 2020 May 1;116(6):1097-1100
pubmed: 32227090
PLoS Negl Trop Dis. 2014 Nov 20;8(11):e3312
pubmed: 25411847
Clin Pharmacokinet. 2012 Jun 1;51(6):e1-18
pubmed: 22550964
Int J Cardiol. 2013 Apr 30;165(1):107-12
pubmed: 21907431
J Am Coll Cardiol. 2020 Jul 7;76(1):122-124
pubmed: 32387623
Int J Cardiol. 2015 Nov 15;199:451-9
pubmed: 26277551
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Eur Heart J Qual Care Clin Outcomes. 2020 Jul 1;6(3):210-216
pubmed: 32467968
J Exp Clin Cancer Res. 2018 Nov 27;37(1):286
pubmed: 30482226
Neurology. 2020 May 12;94(19):809-810
pubmed: 32229625
Rev Esp Cardiol. 2006 Jan;59(1):50-6
pubmed: 16434004
Pharmacotherapy. 2007 Jun;27(6):874-87
pubmed: 17542770
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Clin Res Cardiol. 2020 May;109(5):531-538
pubmed: 32161990
PLoS Negl Trop Dis. 2019 Oct 24;13(10):e0007694
pubmed: 31647811
Heart Rhythm. 2020 Sep;17(9):1463-1471
pubmed: 32387246
Lancet Glob Health. 2020 Aug;8(8):e1018-e1026
pubmed: 32622400
Gut. 2020 Jun;69(6):1002-1009
pubmed: 32213556
Rev Soc Bras Med Trop. 2003 Sep-Oct;36(5):613-5
pubmed: 14576877
Clin Infect Dis. 2016 Oct 15;63(8):1056-1062
pubmed: 27432838
Antimicrob Agents Chemother. 2010 Nov;54(11):4896-9
pubmed: 20823286
Lancet Infect Dis. 2020 Jun;20(6):669-677
pubmed: 32240634
Acta Trop. 2014 Feb;130:167-74
pubmed: 24139912
Nat Rev Immunol. 2020 May;20(5):271-272
pubmed: 32296135
Gut. 2020 Jun;69(6):997-1001
pubmed: 32241899
Mem Inst Oswaldo Cruz. 2009 Jul;104 Suppl 1:311-8
pubmed: 19753490
Curr Oncol Rep. 2020 May 8;22(5):53
pubmed: 32385672
Eur J Clin Pharmacol. 2013 Mar;69(3):743-5
pubmed: 22990328
Glob Heart. 2020 Mar 30;15(1):26
pubmed: 32489799
Rev Soc Bras Med Trop. 2020 Feb 21;53:e20190457
pubmed: 32130325
Lancet. 2010 Apr 17;375(9723):1388-402
pubmed: 20399979
JAMA. 2007 Nov 14;298(18):2171-81
pubmed: 18000201
J Intern Med. 2020 Oct;288(4):469-476
pubmed: 32498135
Eur J Clin Invest. 2009 Jul;39(7):618-25
pubmed: 19453650
Arq Bras Cardiol. 2008 Nov;91(5):306-10
pubmed: 19142374
Infect Dis Poverty. 2020 May 11;9(1):51
pubmed: 32393333
Rev Esp Cardiol. 2009 Nov;62(11):1224-32
pubmed: 19889333
Wkly Epidemiol Rec. 2015 Feb 6;90(6):33-43
pubmed: 25671846
Rev Soc Bras Med Trop. 2009 Nov-Dec;42(6):622-8
pubmed: 20209343
Nat Rev Cardiol. 2012 Oct;9(10):576-89
pubmed: 22847166
Rev Soc Bras Med Trop. 2011 Mar-Apr;44(2):213-6
pubmed: 21503552
JAMA. 2020 May 12;323(18):1775-1776
pubmed: 32203977
Am J Health Syst Pharm. 2000 Sep 1;57(17):1579-84
pubmed: 10984808
Rev Soc Bras Med Trop. 1999 Sep-Oct;32(5):475-82
pubmed: 10881079
Clin Infect Dis. 2015 Sep 15;61(6):918-26
pubmed: 26063720
Arq Bras Cardiol. 2015 Mar;104(3):209-17
pubmed: 25517391
J Am Coll Cardiol. 2020 Jun 16;75(23):2950-2973
pubmed: 32311448
Clin Neurol Neurosurg. 2020 Jul;194:105921
pubmed: 32422545
Cardiol Clin. 2017 Feb;35(1):31-47
pubmed: 27886788
Eur Heart J Cardiovasc Imaging. 2018 Apr 1;19(4):459-460n
pubmed: 29029074
Clin Pharmacokinet. 1996 Feb;30(2):141-79
pubmed: 8906896
Medicina (B Aires). 2020;80(3):271-274
pubmed: 32442941
Int J Cardiol. 2010 Nov 19;145(2):362-363
pubmed: 20399519
Expert Rev Cardiovasc Ther. 2015 Dec;13(12):1393-409
pubmed: 26496376
Circulation. 2018 Sep 18;138(12):e169-e209
pubmed: 30354432
JACC Basic Transl Sci. 2020 Apr 10;5(5):537-542
pubmed: 32292847
J Cardiovasc Magn Reson. 2015 Nov 18;17:97
pubmed: 26581396
Trop Med Int Health. 2012 May;17(5):595-603
pubmed: 22487303
J Antimicrob Chemother. 2018 Apr 1;73(4):1115-1116
pubmed: 29309621
Lancet Glob Health. 2020 Jul;8(7):e877-e878
pubmed: 32333854
Rev Soc Bras Med Trop. 2009 Sep-Oct;42(5):484-7
pubmed: 19967227
Circ Heart Fail. 2020 May;13(5):e007219
pubmed: 32352841
BJOG. 2014 Jan;121(1):22-33
pubmed: 23924273
Cardiovasc Res. 2020 Aug 1;116(10):1666-1687
pubmed: 32352535
Nat Rev Cardiol. 2020 May;17(5):259-260
pubmed: 32139904
Semin Immunopathol. 2020 Jun;42(3):231-246
pubmed: 32189034

Auteurs

Ezequiel José Zaidel (EJ)

Sanatorio Güemes, Buenos Aires, AR.
Pharmacology Department, School of Medicine, University of Buenos Aires, AR.

Colin J Forsyth (CJ)

Drugs for Neglected Diseases initiative-Latin America, Rio de Janeiro, BR.

Gabriel Novick (G)

Swiss Medical Group, Buenos Aires, AR.
Friedman School of Nutrition Science and Policy, Tufts University, Boston, US.

Rachel Marcus (R)

Latin American Society of Chagas, Washington, DC, US.

Antonio Luiz P Ribeiro (ALP)

Internal Medicine Department, School of Medicine, Federal University of Minas Gerais (UFMG), Belo Horizonte, BR.
Hospital das Clínicas, UFMG, Belo Horizonte, BR.

Maria-Jesus Pinazo (MJ)

ISGlobal, Hospital Clínic - University of Barcelona, Barcelona, ES.

Carlos A Morillo (CA)

Libin Cardiovascular Institute, University of Calgary, Calgary, CA.

Luis Eduardo Echeverría (LE)

Department of Cardiology, Cardiovascular Foundation of Colombia, Floriblanca, CO.

Maria Aparecida Shikanai-Yasuda (MA)

Department of Infectious and Parasitic Diseases, School of Medicine, University of São Paulo, São Paulo, BR.

Pierre Buekens (P)

Tulane University School of Public Health and Tropical Medicine, New Orleans, US.

Pablo Perel (P)

World Heart Federation, Geneva, CH.
Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.

Sheba K Meymandi (SK)

Center of Excellence for Chagas Disease at Olive View-UCLA Medical Center, Sylmar, US.

Kate Ralston (K)

World Heart Federation, Geneva, CH.

Fausto Pinto (F)

World Heart Federation, Geneva, CH.
Department of Cardiology, CCUL, Lisbon School of Medicine, Universidade de Lisboa, PT.

Sergio Sosa-Estani (S)

Drugs for Neglected Diseases initiative-Latin America, Rio de Janeiro, BR.
Epidemiology and Public Health Research Center, (CIESP-CONICET), Buenos Aires, AR.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH